Magnetic resonance imaging (MRI) is a safe diagnostic tool and over 500 million diagnostic studies have been performed safely up to now. However, there have been at least 15 published cases of patient deaths associated with MRI scanning; 10 cases with implanted pacemakers [1–5], 2 patients with an insulin pump , 1 patient with a neuro-stimulator, 1 patient with an aneurysm clip , and 1 child killed by an oxygen tank . Additionally, hundreds of severe burns  or injuries due to ferromagnetic projectiles have also been reported. The loud noises (up to 120 dBA) induced by the fast switching gradient fields make ear protections mandatory for all patient. The sources of all these risks are the electromagnetic fields of the MRI scanner.
KeywordsMagnetic Resonance Imaging Acute Kidney Injury Nephrogenic Systemic Fibrosis Specific Absorption Rate Aneurysm Clip
- 3.The Joint Commission. Preventing MRI accident and injuries. Sentinel Event Alert, 14 Feb 2008.Google Scholar
- 5.Schiebler M, Kaut-Watson C, Williams DL. Both sedated and critically ill require monitoring during MRI (survey).MR. 1994;Winter:41–5.Google Scholar
- 7.Boy, 6, Dies of skull injury during M.R.I. The New York Times, 31 July 2001.Google Scholar
- 9.ACR. ACR manual on contrast media (Version 8), American College of Radiology, Editor; 2012. Available from: http://www.acr.org/Quality-Safety/Resources/Contrast-Manual. Accessed on 9, 2012).
- 14.Shellock FG. Reference manual for magnetic resonance safety, implants, and devices, 2011 edition. Los Angeles: Biomedical Research Publishing Group; 2011.Google Scholar
- 15.Levine GN, et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American heart association scientific statement from the committee on diagnostic and interventional cardiac catheterization, council on clinical cardiology, and the council on cardiovascular radiology and intervention: endorsed by the American college of cardiology foundation, the North American society for cardiac imaging, and the society for cardiovascular magnetic resonance. Circulation. 2007;116(24):2878–91.PubMedCrossRefGoogle Scholar
- 26.FDA. FDA drug safety communication: new warnings for using gadolinium-based contrast agents in patients with kidney dysfunction. 2010. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm223966.htm. Accessed on 9, 2012.